Nuwellis (NUWE) Competitors $0.20 -0.02 (-10.71%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$0.20 +0.00 (+0.51%) As of 07/3/2025 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. CHEK, HSCS, ICU, AMIX, TIVC, AEMD, TTOO, PSTV, VERO, and BBLGShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Check-Cap (CHEK), HeartSciences (HSCS), SeaStar Medical (ICU), Autonomix Medical (AMIX), Tivic Health Systems (TIVC), Aethlon Medical (AEMD), T2 Biosystems (TTOO), Plus Therapeutics (PSTV), Venus Concept (VERO), and Bone Biologics (BBLG). These companies are all part of the "medical equipment" industry. Nuwellis vs. Its Competitors Check-Cap HeartSciences SeaStar Medical Autonomix Medical Tivic Health Systems Aethlon Medical T2 Biosystems Plus Therapeutics Venus Concept Bone Biologics Nuwellis (NASDAQ:NUWE) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation. Do analysts rate NUWE or CHEK? Nuwellis presently has a consensus price target of $17.00, suggesting a potential upside of 8,573.47%. Given Nuwellis' stronger consensus rating and higher possible upside, analysts plainly believe Nuwellis is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuwellis 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation & earnings, NUWE or CHEK? Nuwellis has higher revenue and earnings than Check-Cap. Check-Cap is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuwellis$8.79M0.10-$11.16M-$18.24-0.01Check-CapN/AN/A-$17.57M-$3.00-0.24 Do institutionals & insiders hold more shares of NUWE or CHEK? 3.1% of Nuwellis shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 1.6% of Nuwellis shares are owned by company insiders. Comparatively, 0.5% of Check-Cap shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is NUWE or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Nuwellis' net margin of -112.09%. Check-Cap's return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Nuwellis-112.09% -655.31% -141.83% Check-Cap N/A N/A N/A Does the media refer more to NUWE or CHEK? In the previous week, Nuwellis had 4 more articles in the media than Check-Cap. MarketBeat recorded 5 mentions for Nuwellis and 1 mentions for Check-Cap. Nuwellis' average media sentiment score of 0.00 equaled Check-Cap'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nuwellis 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, NUWE or CHEK? Nuwellis has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. SummaryNuwellis beats Check-Cap on 10 of the 14 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$857K$6.85B$5.49B$9.01BDividend YieldN/A1.23%5.38%4.09%P/E Ratio-0.0126.6327.4220.26Price / Sales0.1099.59407.97121.21Price / CashN/A20.9736.6357.47Price / Book0.134.748.085.67Net Income-$11.16M$173.18M$3.16B$248.47M7 Day Performance-17.54%1.33%2.81%3.29%1 Month Performance-74.55%-0.41%3.68%5.19%1 Year Performance-95.24%28.42%35.29%21.35% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis1.8622 of 5 stars$0.20-10.7%$17.00+8,573.5%-95.2%$857K$8.79M-0.0170News CoverageGap DownCHEKCheck-Cap0.4946 of 5 stars$0.73-2.7%N/A-63.7%$4.27MN/A-0.2480News CoveragePositive NewsGap UpHSCSHeartSciences1.6674 of 5 stars$3.83+1.1%$13.00+239.4%-22.6%$4.14M$20K-0.5110News CoverageICUSeaStar Medical1.4236 of 5 stars$0.36+8.3%N/A-94.1%$4.03M$140K-0.102Gap DownHigh Trading VolumeAMIXAutonomix Medical3.3023 of 5 stars$1.26-6.0%$16.50+1,209.5%-89.0%$3.50MN/A-0.171Positive NewsGap DownTIVCTivic Health Systems0.8011 of 5 stars$3.92+1.3%N/A-37.4%$3.45M$780K0.0010AEMDAethlon Medical2.746 of 5 stars$1.62+15.7%$56.00+3,356.8%-60.3%$3.26M$570K-0.1310Analyst RevisionTTOOT2 Biosystems2.4659 of 5 stars$0.15+15.4%$5.00+3,202.5%-97.2%$3.19M$7.68M0.00180Gap UpPSTVPlus Therapeutics1.7106 of 5 stars$0.19+3.9%$11.67+6,138.9%-80.7%$3.18M$5.82M-0.0620High Trading VolumeVEROVenus Concept1.1889 of 5 stars$2.20-0.9%N/A-61.0%$3.13M$61.00M-0.03410BBLGBone Biologics1.1218 of 5 stars$5.54-10.7%N/A-51.7%$3.04MN/A0.002 Related Companies and Tools Related Companies CHEK Alternatives HSCS Alternatives ICU Alternatives AMIX Alternatives TIVC Alternatives AEMD Alternatives TTOO Alternatives PSTV Alternatives VERO Alternatives BBLG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUWE Stock Alerts